Lannett Overview
- Year Founded
-
1942
- Status
-
Public
- Employees
-
305
- Investments
-
5
- Share Price
-
$2.52
- (As of Tuesday Closing)
Lannett General Information
Description
Developer of generic medicine intended to save and enhance people's lives. The company develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products and it offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages and also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. and it operates in the segment of generic pharmaceuticals, thereby serving customers including generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Contact Information
Website
www.lannett.comCorporate Office
- 1150 Northbrook Drive
- Suite 155
- Trevose, PA 19053
- United States
Corporate Office
- 1150 Northbrook Drive
- Suite 155
- Trevose, PA 19053
- United States
Lannett Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.52 | $2.54 | $1.54 - $3.75 | $35M | 10.8M | -$18.93 |
Lannett Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 30-Jun-2022 | FY 2021 30-Jun-2021 | FY 2020 30-Jun-2020 |
|---|---|---|---|---|
| EV | 598,254 | 541,283 | ||
| Revenue | 310,669 | 340,579 | 478,778 | 545,744 |
| EBITDA | (171,368) | (141,678) | (201,196) | 74,526 |
| Net Income | (259,092) | (231,620) | (363,475) | (33,366) |
| Total Assets | 334,624 | 484,435 | 683,737 | 1,136,555 |
| Total Debt | 639,628 | 627,006 | 603,775 | 692,070 |
Lannett Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lannett Comparisons
Industry
Financing
Details
000000
000000
Lannett Competitors (35)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sagent Pharmaceuticals | Corporate Backed or Acquired | Chicago, IL | 000 | 00000 | 000000&0 | |
| Rising Pharmaceuticals | Private Equity-Backed | East Brunswick, NJ | 000 | 00000000000 | ||
| Camber Pharmaceuticals | Corporation | Piscataway, NJ | 000 | 000000000 - | ||
| Doc Generici | Private Equity-Backed | Milan, Italy | 000 | 000000000000 | ||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | 00 | 00000000 |
Lannett Patents
Lannett Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160030723-A1 | Multi-chamber anesthetic delivery system | Inactive | 15-Mar-2013 | 0000000000 | 0 |
| US-20090148512-A1 | Novel uses of chloramphenicol and analogous thereof | Inactive | 07-Dec-2007 | 0000000000 | 0 |
| AU-1835895-A | Application and method for communication switching | Inactive | 31-Jan-1994 | H04L12/44 |
Lannett Executive Team (12)
| Name | Title | Board Seat |
|---|---|---|
| Martin Galvan | Vice President of Finance, Chief Financial Officer and Treasurer | |
| Maureen Cavanaugh | Senior Vice President & Chief Commercial Operations Officer | |
| John Abt Ph.D | Vice President & Chief Quality and Operations Officer | |
| John Kozlowski | Chief of Staff and Strategy Officer | |
| Robert Ehlinger | Vice President & Chief Information Officer |
Lannett Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000 | Self | Board Member | 000 0000 |
| 0000 0000000 | Self | Board Member | 000 0000 |
Lannett Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Lannett Investments & Acquisitions (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Endo International (Portfolio of Generic Products) | 07-May-2018 | 000000000 | 0000 | Buildings and Property | 0000000 0 |
| Kremers Urban Pharmaceuticals | 25-Nov-2015 | 0000000000 | 00.000 | Pharmaceuticals | 000000 00 |
| Silarx Pharmaceuticals | 01-Jun-2015 | 0000000000 | 000.00 | Pharmaceuticals | 000000 00 |
| Lannett Company (Two Generic Pharmaceutical Products) | 20-Aug-2014 | 0000000000 | Pharmaceuticals | 000000 00 | |
| Cody Laboratories | 10-Apr-2007 | Merger/Acquisition | Pharmaceuticals | 000000 00 |
Lannett Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Lannett Company (Liquid Drug Manufacturing Plant And Other Assets in Carmel, New York) | Other Pharmaceuticals and Biotechnology | Carmel, NY |
Lannett ESG
Risk Overview
Risk Rating
Updated December, 14, 2022
30.65 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
Percentile
Pharmaceuticals
Industry
00 of 895
Rank
Percentile
Pharmaceuticals
Subindustry
00 of 429
Rank
Percentile
Lannett Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Cody Laboratories | 10-Apr-2007 | 000000000000 | Completed |
|
Lannett FAQs
-
When was Lannett founded?
Lannett was founded in 1942.
-
Where is Lannett headquartered?
Lannett is headquartered in Trevose, PA.
-
What is the size of Lannett?
Lannett has 305 total employees.
-
What industry is Lannett in?
Lannett’s primary industry is Pharmaceuticals.
-
Is Lannett a private or public company?
Lannett is a Public company.
-
What is the current stock price of Lannett?
As of 07-Feb-2023 the stock price of Lannett is $2.52.
-
What is the current market cap of Lannett?
The current market capitalization of Lannett is $35M.
-
What is Lannett’s current revenue?
The trailing twelve month revenue for Lannett is $311M.
-
Who are Lannett’s competitors?
Sagent Pharmaceuticals, Rising Pharmaceuticals, Camber Pharmaceuticals, Doc Generici, and GlaxoSmithKline Consumer Nigeria are some of the 35 competitors of Lannett.
-
What is Lannett’s annual earnings per share (EPS)?
Lannett’s EPS for 12 months was -$18.93.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
